我国东部地区部分省市核医学放射卫生防护现状调查

摘要/Abstract

摘要： 国内现有的针对核医学防护的调查研究大多局限于某家医疗机构,或是较小范围内的现状调查,所得出的结论较为局限。本研究以我国东部地区7个省/直辖市共28家医疗机构核医学科为研究对象,通过实地调研的方式,对各医院核医学科的场所设置、设备配置、核素来源、场所监测和放射防护管理现状等情况进行了分析,发现部分医院核医学科存在场所选址布局不合理、设备较老旧以及性能检测不完善等问题。日后的放射防护及监督工作应注意此类问题并提出相应解决方法。

关键词: 核医学, 放射防护, 现状调查

Abstract: Most of the current investigations on radiation protection for nuclear medicine in China were limited to a single medical institution or a small-scale area. The conclusions obtained were rather one-sided. To be more comprehensive and representative, a total of 28 medical institutions in 7 provinces/municipalities in the eastern part of China were selected and a field research on nuclear medicine departments were conducted in our study. We investigated the following aspects in 28 hospitals including site setting, equipment configuration, sources of radionuclide, site monitoring and current status of radiation protection management. It was found that some hospitals had problems in unreasonable site selection, poor equipment condition and imperfect performance testing. More attention should be paid to such problems in future radiation protection and supervision work while corresponding solutions should be proposed too.

Key words: nuclear medicine, radiation protection, status investigation

中图分类号:

唐波, 巫文威, 涂彧. 我国东部地区部分省市核医学放射卫生防护现状调查[J]. 辐射防护, 2018, 38(6): 522-528.

TANG Bo, WU Wenwei, TU Yu. Investigation on radiation protection situation for nuclear medicine in cities of eastern China[J]. RADIATION PROTECTION, 2018, 38(6): 522-528.

参考文献

[1] UNSCEAR. Sources and ffects of ionizing radiation[R]. United Nations, New York, 2008.
[2] Yeong C H, Cheng M H, Ng K H. Therapeutic radionuclides in nuclear medicine: current and future prospects[J].J Zhejiang Univ Sci B, 2014,15(10):845-863.
[3] ZHAO Y, Adjei A A. Targeting angiogenesis in cancer therapy: moving beyond vascular endothelial growth factor[J]. Oncologist, 2015,20(6):660-673.
[4] Taurone S, Galli F, Signore A, et al. VEGF in nuclear medicine: Clinical application in cancer and future perspectives (Review) [J]. Int J Oncol, 2016, 49(2):437-447.
[5] Selberg K, Ross M. Advances in nuclear medicine[J]. Veterinary Clinics of North America: Equine Practice, 2012, 28(3):527-538.
[6] Van der Wall H, Lee A, Magee M, et al. Radionuclide bone scintigraphy in sports injuries[J]. Semin Nucl Med, 2010, 40(1):16-30.
[7] Girjoaba O, Cucu A. Romanian medical exposure to ionising radition in 2012.[J]. Radiat Prot Dosimetry, 2015, 165(1-4):137.
[8] Roberts F O, Gunawardana D H, Pathmaraj K, et al. Radiation dose to PET technologists and strategies to lower occupational exposure.[J]. Journal of Nuclear Medicine Technology, 2005, 33(1):44-47.
[9] Chiesa C, De S V, Crippa F, et al. Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose[J]. European Journal of Nuclear Medicine, 1997, 24(11):1380.
[10] Bolus N. Review of common occupational hazards and safety concerns for nuclear medicine technologists[J]. Journal of Nuclear Medicine Technology,2008, 36(1):11.
[11] Summers E C, Brown J L, Bownes P J, et al. Eye doses to staff in a nuclear medicine department[J]. Nuclear Medicine Communications, 2012, 33(5):476-480.
[12] Leidesvegborn S. External radiation exposure of personnel in nuclear medicine from ¹⁸F, ^99mTc and ¹³¹I with special reference to fingers, eyes and thyroid[J]. Radiation Protection Dosimetry, 2012, 149(2):196.
[13] Kaljevic J, Stankovic K, Stankovic J, et al.Hand dose evaluation of occupationally exposed staff in nuclear medicine[J]. Radiation Protection Dosimetry, 2015, 170(1):v500.
[14] Bernier M O, Journy N, Villoing D, et al. Cataract risk in a cohort of U.S. radiologic technologists performing nuclear medicine procedures[J]. Radiology, 2017:170683.
[15] Kopec R, Budzanowski M, Budzyńska A, et al. On the relationship between whole body, extremity and eye lens doses for medical staff in the preparation and application of radiopharmaceuticals in nuclear medicine[J]. Radiation Measurements, 2011, 46(11):1 295-1 298.
[16] Dabin J, Kopec R, Struelens L, et al.Eye lens doses in nuclear medicine: A multicentric study in Belgium and Poland.[J]. Radiat Prot Dosimetry, 2016, 170(1-4):297-301.
[17] Brudecki K, Kowalska A, Zagrodzki P, et al. Measurement of ¹³¹I activity in thyroid of nuclear medical staff and internal dose assessment in a Polish nuclear medical hospital[J]. Radiation & Environmental Biophysics, 2017, 56(1):19-26.
[18] Zanotti-Fregonara P, Hindie E. Performing nuclear medicine examinations in pregnant women[J]. Physics Medica, 2017.
[19] Stabin M G. Radiation dose and risks to fetus from nuclear medicine procedures[J]. Phys Med, 2017, 43.
[20] Sparks R B. Placental transfer of radiopharmaceuticals and dosimetry in pregnancy[J]. Health Physics, 1997, 73(5):747-755.
[21] Fahey F, Stabin M. Dose optimization in nuclear medicine[J]. Seminars in Nuclear Medicine, 2014, 44(3):193-201.
[22] Fahey F H, Treves S T, Adelstein S J. Minimizing and communicating radiation risk in pediatric nuclear medicine[J]. J Nucl Med Technol, 2012, 40(1):13-24.
[23] Song H C. Current global and Korean issues in radiation safety of nuclear medicine procedures[J]. Annals of the Icrp, 2016, 45(1 Suppl):122.
[24] 杨宇华,杨浩贤,贾育新. 广东省临床核医学医疗照射水平调查[J]. 中国辐射卫生, 2004, 13(2):135-136.
[25] 李宁,肖国有,廖光星,等. 某医院核医学科放射卫生防护分析[J]. 中国卫生标准管理, 2015,(32):16-18.
[26] 王宏芳,娄云,万玲,等. 核医学科操作人员及相关场所辐射水平调查[J]. 现代预防医学, 2015, 42(4):601-603.
[27] 中华人民共和国主席令,第81号. 中华人民共和国职业病防治法[S]. 2016.
[28] 中华人民共和国卫生部令,第46号. 放射诊疗管理规定[S]. 2006.
[29] 上海医科大学放射医学研究所. 临床核医学放射卫生防护标准:GBZ 120—2006[S]. 2006.
[30] 曹厚德.放射工作人员职业健康监护技术规范[J]. 中国医学计算机成像杂志, 2011,(2):130.